|Articles|October 1, 2006

Derms protest planned FDA ban

Schaumburg, Ill. - The American Academy of Dermatology (AAD) will object to a proposed federal ban of over-the-counter sales of hydroquinone.

Schaumburg, Ill. - The American Academy of Dermatology (AAD) will object to a proposed federal ban of over-the-counter sales of hydroquinone.

The Food and Drug Administration (FDA) has declared that products containing the bleaching agent pose risks of cancer and skin discoloration, and has proposed a ban on nonprescription sales.

If the agent is banned, all existing cosmetic products containing hydroquinone would need to submit a new drug application for the FDA's review, according to news reports.


Related to this article

TanPrevent and the Case for Preventing Thousands of Melanomas
Learn why indoor tanning remains a preventable source of melanoma, what research suggests about why some patients experience difficulty stopping, and how a clinical pilot called TanPrevent could connect education with follow-up support to help them quit and stay quit.
Journal Digest: November 16
Recent dermatology research explores chronic hand eczema prevalence, cancer risk in morphea, pernio, biologic optimization in HS, and melanoma risk prediction.